Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-3

Completed · Phase 3 · Has a placebo group

Conditions studied: Dry Eye Syndromes, Dry Eye

In brief

The objective of this study is to compare the safety and efficacy of RGN-259 Ophthalmic Solution to placebo for the treatment of the signs and symptoms of dry eye.

Key facts

Study ID
NCT03937882
Run by
ReGenTree, LLC
People needed
700
Starts
2019-05-24
Expected to finish
2021-10-07
Last updated by the study team
2022-05-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.